111 related articles for article (PubMed ID: 16521343)
21. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
22. Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
Boogaerts M; Maertens J; van Hoof A; de Bock R; Fillet G; Peetermans M; Selleslag D; Vandercam B; Vandewoude K; Zachée P; De Beule K
J Antimicrob Chemother; 2001 Jul; 48(1):97-103. PubMed ID: 11418517
[TBL] [Abstract][Full Text] [Related]
23. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Glasmacher A; Hahn C; Molitor E; Marklein G; Sauerbruch T; Schmidt-Wolf IG
Mycoses; 1999; 42(11-12):591-600. PubMed ID: 10680434
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?
Iriyama N; Matsukawa Y; Miura K; Inomata H; Hirabayashi Y; Hatta Y; Horikoshi A; Takeuchi J
J Infect Chemother; 2011 Dec; 17(6):744-9. PubMed ID: 21523410
[TBL] [Abstract][Full Text] [Related]
25. Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
Mochizuki M; Murase S; Takahashi K; Shimada S; Kume H; Iizuka T; Fukuda M
Nihon Ishinkin Gakkai Zasshi; 2000; 41(1):33-9. PubMed ID: 10660641
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
28. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
Glasmacher A; Hahn C; Leutner C; Molitor E; Wardelmann E; Losem C; Sauerbruch T; Marklein G; Schmidt-Wolf IG
Mycoses; 1999; 42(7-8):443-51. PubMed ID: 10546485
[TBL] [Abstract][Full Text] [Related]
29. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
Ohta K; Nishiki Kosaka S; Nakao Y; Kumura T; Hagihara K; Sakamoto E; Okamoto S; Hirose A; Aoyama Y; Yamamura R; Hayashi Y; Umemoto Y; Terada Y; Takeoka Y; Nakane T; Koh H; Hino M
Int J Hematol; 2009 Jun; 89(5):649-55. PubMed ID: 19449195
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
[TBL] [Abstract][Full Text] [Related]
32. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
33. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
34. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
Nakamura Y; Matsumoto K; Sato A; Morita K
J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
[TBL] [Abstract][Full Text] [Related]
35. [Improvement of patient adherence by mixing oral itraconazole solution with a beverage (orange juice)].
Adachi Y; Sumikuma T; Kagami R; Nishio A; Akasaka K; Tsunemine H; Kodaka T; Hiramatsu Y; Tada H
Rinsho Ketsueki; 2010 May; 51(5):315-9. PubMed ID: 20534951
[TBL] [Abstract][Full Text] [Related]
36. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T
Int J Hematol; 2007 Feb; 85(2):121-7. PubMed ID: 17321989
[TBL] [Abstract][Full Text] [Related]
37. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
38. Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Glasmacher A; Hahn C; Molitor E; Sauerbruch T; Schmidt-Wolf IG; Marklein G
Mycoses; 1999; 42(5-6):395-402. PubMed ID: 10536431
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropenia.
Kanbayashi Y; Nomura K; Fujimoto Y; Shimura K; Shimizu D; Okamoto K; Matsumoto Y; Horiike S; Shimazaki C; Takagi T; Taniwaki M
Int J Antimicrob Agents; 2008 May; 31(5):452-7. PubMed ID: 18359202
[TBL] [Abstract][Full Text] [Related]
40. [Fungal infections in hematology patients and after blood stem cell transplantation: prophylaxis and treatment].
Egerer G; Schmitt T
Med Klin Intensivmed Notfmed; 2014 Oct; 109(7):526-30. PubMed ID: 23576010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]